Dr Paul Wilkinson

Collaborators

Key publications

Wilkinson P, Kelvin R, Roberts C, Dubicka B, Goodyer I (2011), “Clinical and psychosocial predictors of suicide attempts and nonsuicidal self-injury in the Adolescent Depression Antidepressants and Psychotherapy Trial (ADAPT).” Am J Psychiatry 168(5):495-501 Details

Wilkinson P, Dubicka B, Kelvin R, Roberts C, Goodyer I (2009), “Treated depression in adolescents: predictors of outcome at 28 weeks.” Br J Psychiatry 194(4):334-41 Details

Goodyer I, Dubicka B, Wilkinson P, Kelvin R, Roberts C, Byford S, et al (2007), “Adolescent Depression Antidepressant and Psychotherapy Trial (ADAPT). A Randomised Controlled Trial of SSRIs with and without cognitive behaviour therapy in adolescents with major depression” BMJ 335:142

Publications

2011

Dunn VJ, Abbott RA, Croudace TJ, Wilkinson P, Jones PB, Herbert J, Goodyer IM (2011), “Profiles of family-focused adverse experiences through childhood and early adolescence: the ROOTS project a community investigation of adolescent mental health.” BMC Psychiatry 11:109 Details

Gardner J Wilkinson P (2011), “Is family therapy the most effective treatment for anorexia nervosa? ” Psychiatria Danubina 23(SUPPL. 1):S175-S177

Goodyer IM, Tsancheva S, Byford S, Dubicka B, Hill J, Kelvin R, Reynolds S, Roberts C, Senior R, Suckling J, Wilkinson P, Target M, Fonagy P (2011), “Improving mood with psychoanalytic and cognitive therapies (IMPACT): a pragmatic effectiveness superiority trial to investigate whether specialised psychological treatment reduces the risk for relapse in adolescents with moderate to severe unipolar depression: study protocol for a randomised controlled trial.” Trials 12:175 Details

Wilkinson P, Goodyer I (2011), “Non-suicidal self-injury.” Eur Child Adolesc Psychiatry 20(2):103-8 Details

Wilkinson PO, Goodyer IM (2011), “Childhood adversity and allostatic overload of the hypothalamic-pituitary-adrenal axis: a vulnerability model for depressive disorders.” Dev Psychopathol 23(4):1017-37 Details

Wilkinson, P (2011), “Non-Suicidal Self-Injury: a Clear Marker for Suicide Risk” JAACAP 50: 71-72

2010

Bhardwaj A, Wilkinson P, Srivastava C, Sharma M (2010), “Cognitive deficits in euthymic patients with recurrent depression.” J Nerv Ment Dis 198(7):513-5 Details

Dubicka B Wilkinson P Kelvin R Goodyer I (2010), “Pharmacological treatment of depression and bipolar disorder in children and adolescents” Advances in Psychiatric Treatment 16:402-412

Dubicka B, Elvins R, Roberts C, Chick G, Wilkinson P, Goodyer IM (2010), “Combined treatment with cognitive-behavioural therapy in adolescent depression: meta-analysis.” Br J Psychiatry 197:433-40 Details

Goodyer IM, Wilkinson P, Dubicka B, Kelvin R (2010), “Forum: the use of selective serotonin reuptake inhibitors in depressed children and adolescents: commentary on the meta-analysis by Hetrick et al.” Curr Opin Psychiatry 23(1):58-61 Details

Laura M Wilkinson P (2010), “Perinatally Acquired HIV and Emotional Disorders in Children” Acta Paediatrica 99 (Suppl 462): 89

Wilkinson, P (2010), “Diagnosing and treating depression in adolescents” European Paediatrics 4:77-80

Wilkinson, P (2010), “Predictors of Outcome of Treated Depression in Adolescents” Mind & Brain, The Journal of Psychiatry 1(1): 49-53

2009

Tomlinson D Wilkinson H Wilkinson P (2009), “Diet and Mental Health in Children and Adolescents” Child and Adolescent Mental Health 14(3): 148-155

Wilkinson P (2009), “In adolescents with SSRI resistant depression, CBT/combined treatment is most effective in those with comorbid disorders.” Evid Based Ment Health 12(4):108 Details

Wilkinson P (2009), “Conceptualization about internalizing problems in children and adolescents.” Cien Saude Colet 14(2):373-81 Details

Wilkinson, P (2009), “Which Risk Factors at Baseline and During Treatment Predict Short-Term Persistence of Major Depression in Adolescents? ” European Psychiatric Review 2(2): 21-24

Wilkinson, P (2009), “Depression in Childhood and Adolescence” London Journal of Primary Care 2(1): 15-20

2008

Goodyer IM, Dubicka B, Wilkinson P, Kelvin R, Roberts C, Byford S, Breen S, Ford C, Barrett B, Leech A, Rothwell J, White L, Harrington R (2008), “A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.” Health Technol Assess 12(14):iii-iv, ix-60 Details

Wilkinson PO, Goodyer IM (2008), “The effects of cognitive-behavioural therapy on mood-related ruminative response style in depressed adolescents.” Child Adolesc Psychiatry Ment Health 2(1):3 Details

Wilkinson, P Goodyer, I (2008), “Attention in Adolescents Recovered from Major Depression” European Neuropsychopharmacology 18S1:S43-S44

2007

Byford S Barrett B Roberts C Wilkinson P Dubicka B Kelvin R White L Ford C Breen S Goodyer I (2007), “Cost-effectiveness of selective serotonin reuptake inhibitors and routine specialist care with and without cognitive behavioural therapy in adolescents with major depression” B J Psych 191:521-527

Byford S, Barrett B, Roberts C, Wilkinson P, Dubicka B, Kelvin RG, White L, Ford C, Breen S, Goodyer I (2007), “Cost-effectiveness of selective serotonin reuptake inhibitors and routine specialist care with and without cognitive behavioural therapy in adolescents with major depression.” Br J Psychiatry 191:521-7 Details

Dubicka B, Wilkinson P (2007), “Evidence-based treatment of adolescent major depression.” Evid Based Ment Health 10(4):100-2 Details

Goodyer I, Dubicka B, Wilkinson P, Kelvin R, Roberts C, Byford S, Breen S, Ford C, Barrett B, Leech A, Rothwell J, White L, Harrington R (2007), “Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: randomised controlled trial.” BMJ 335(7611):142 Details

2006

Wilkinson PO, Goodyer IM (2006), “Attention difficulties and mood-related ruminative response style in adolescents with unipolar depression.” J Child Psychol Psychiatry 47(12):1284-91 Details

2005

Wilkinson P (2005), “Continuing fluoxetine treatment may delay relapse in children and adolescents with major depressive disorder.” Evid Based Ment Health 8(2):37 Details

2004

Wilkinson P (2004), “A controversy too far?” BMJ 329(7479):1397 Details